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Abstract

Noninvasive hemodynamic monitoring has evolved steadily over the past few decades in
response to healthcare providers' preference for less invasive monitoring methods for their patients.
Invasive monitoring has its place in the critically ill patient population as witnessed in intensive care
units throughout the country. Even in this environment, providers are opting less for the pulmonary
artery catheter which has been the gold standard for invasive cardiac output monitoring in the past.
Providers are now utilizing less invasive monitoring techniques which offer fewer potential
complications to the patient while providing rapid access to critically important hemodynamic data.
Examination of different noninvasive hemodynamic monitoring systems was completed in a literature
review. The findings indicate that clinical accuracy is variable from device to device, however as
technology has progressed there has been general improvement in this area. The appropriate clinical
use for noninvasive hemodynamic monitoring is discussed based on evidence from the literature with a
focus on the benefits and drawbacks that are associated with these systems as they specifically apply to
the emergent trauma patient population.

Introduction
Noninvasive monitoring technology is uniquely poised to be of great benefit to the emergent
trauma patient population. Knowing these patients’ hemodynamic status is critical to guiding
management of these patients appropriately in the early stages of injury and resuscitation. Traditional
monitoring of emergency trauma patients includes vital signs, urine output, and mental status. One of
the problems with treating trauma patients solely by traditional measurements is that by the time there
is a change noticed, the patient has decompensated towards a state of shock. As a patient’s
hemodynamic status worsens, their response to treatment also worsens, thus making correction of the
injury increasingly difficult. Non-invasive monitoring techniques provide early recognition of changes in
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hemodynamic status thus allowing for early treatment and improved responses to treatment. This preemptive treatment is critical for preventing hypoperfusion which can lead to irreversible organ damage,
shock, and ultimately, death. Understanding the risks and benefits of noninvasive hemodynamic
monitoring will help the nurse anesthetist to determine the appropriate application of these
technologies towards improving the outcomes of their patients. This literature review examines the
clinical research and application of various noninvasive hemodynamic techniques over the past 17 years.
There have been multiple investigations of how noninvasive hemodynamic monitoring can be utilized in
the hospital and emergency setting. The purpose of this literature review is to examine the evolution
and application of specific noninvasive hemodynamic techniques as they apply to the trauma and
emergency patient population.

Literature Review
Early noninvasive monitoring techniques were investigated by researcher Dr. William C.
Shoemaker and his research colleagues. In 1999, they published a research article that examined the
efficacy of early noninvasive hemodynamic monitoring after severe blunt trauma. They used a newly
developed thoracic bioimpedance device which continually measured cardiac output and provided a
continuous real-time display of data. The goal of the research was to determine if early identification
and treatment of altered hemodynamic status via noninvasive monitoring in trauma patients would lead
to more rapid and improved resuscitation (Velmahos, Wo, Demetriades, and Shoemaker, 1999). They
noted that conventional monitoring which includes blood pressure, urine output, skin color, and mental
status changes does not provide quantitative evaluation of cardiovascular function and these values may
appear normal despite a significant hemodynamic deficit being present (Velmahos, Wo, Demetriades,
and Shoemaker, 1999). The thoracic bioimpedance device was used in combination with a standard
pulse oximeter, blood pressure cuff, a transcutaneous oxygen tension monitor, and a transcutaneous
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carbon dioxide tension monitor. The authors utilized thermodilution from pulmonary artery catheters
to compare cardiac output values measured by the noninvasive monitor. They found a correlation
coefficient which the researchers determined to be acceptable in the clinical setting. “The correlation
coefficient for simultaneous pairs of samples of the two methods was r=0.91, r2=0.83. This is consistent
with previous reports of critically ill patients predominantly in the ICU and was considered to be
reasonably satisfactory from a clinical viewpoint” (Velmahos, Wo, Demetriades, and Shoemaker, 1999).
The research results indicated that survivors and non-survivors had significantly different values as
measured by the noninvasive monitoring which included cardiac index, oxygen saturation, and
percutaneous oxygen and carbon dioxide tensions. They argued that these values could be used in the
early resuscitative period to guide treatment as adequate resuscitation in the initial period after
traumatic injury is critical and may determine patient outcome (Velmahos, Wo, Demetriades, and
Shoemaker, 1999). The authors concluded that the bioimpedance device correlated adequately with
values measured simultaneously by pulmonary artery catheter thermodilution, however there was no
clinically agreed level of acceptance from any other source that could confirm this adequate correlation
between the two measurements; this was considered a limitation of the study (Velmahos, Wo,
Demetriades, and Shoemaker, 1999). Identifying early altered hemodynamic status in emergency
trauma patients via easy to use noninvasive monitoring was an important and clinically useful research
topic that other researchers would continue to build upon.
Dr. Shoemaker was involved in another research project which utilized noninvasive monitoring
as an early warning for the development of ARDS (acute respiratory distress syndrome) in trauma
patients, published in 2000. The goal was to identify appropriate hemodynamic monitoring early after
injury. Pulmonary artery catheterization, which is done in the critical care setting, provides metabolic
oxygen delivery and consumption information, however this invasive monitoring is not readily available
during the early resuscitation period in the emergency environment, whether that be the emergency
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department or operating room (Tatevossian et al., 2000). The researchers continuously monitored
patients with transcutaneous oxygen and carbon dioxide tension measurements which were considered
a substitute for invasive blood gas monitoring which only provides spot checks as opposed to continuous
trending information. Transcutaneous oxygen and carbon dioxide tensions were used to measure skin
oxygenation and perfusion; the authors note that the skin is the first organ to manifest vasoconstriction
and uneven blood flow from sympathetic stress stimulation thus providing a general picture of tissue
perfusion function (Tatevossian et al., 2000). A thoracic electrical bioimpedance device was also used to
monitor cardiac output noninvasively. The results of the study found certain trends that provided useful
information; patients who did not develop ARDS had higher cardiac index and tissue perfusion levels
than those who developed ARDS. The survivors of ARDS had higher cardiac output and tissue perfusion
values than those who died after ARDS. This helped the authors to identify that monitoring and optimal
treatment in the late stages after organ failure was ineffective due to severe oxygen debt already
accumulated (Tatevossian et al., 2000). The authors found that early recognition of changes in tissue
perfusion and cardiac output could guide pre-emptive treatment and decrease the risk that the patient
develops ARDS with the application of these noninvasive monitoring techniques.
Shoemaker et al. (2006) published another article in the journal Military Medicine which
examined how noninvasive monitoring for combat casualties could optimize patient outcomes.
Shoemaker focused again on the importance of early monitoring and resuscitation in patients who had
suffered traumatic injuries. Recognition of altered hemodynamic status is crucial in this initial period
after traumatic injury. Delayed treatment has been shown to lead towards shock, organ failure, and
death. The authors noted that goal directed resuscitation therapy with invasive pulmonary artery
catheterization did not improve outcomes as this monitoring was usually started greater than 24 hours
after hospital admission or after onset of organ failure; however early preoperative hemodynamic
optimization showed significant improvement in patient outcomes (in the setting of peripheral vascular
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surgery, trauma, cardiogenic shock, and sepsis) (Shoemaker et al., 2006). The researchers again used a
thoracic bioimpedance device which was applied to patients shortly after arrival to the emergency
department. They cited previous studies which documented satisfactory correlation between these
noninvasive monitoring devices and the gold standard invasive pulmonary artery catheter
thermodilution measurement of cardiac output. The authors did note the limitations of the
bioimpedance device which is attached via thoracic electrode pads; these include faulty electrode
placement, motion artifacts, patient restlessness, shivering, pulmonary edema, pleural effusion, valvular
heart disease, dysrhythmias, and electrical leak from instruments using the same circuit (Shoemaker et
al., 2006). The study included 851 patients who survived and 149 patients who died during
hospitalization with the mortality rate at 14.9%. The authors generalized these large city trauma
patients to similar combat casualties with the hypothesis that early noninvasive monitoring application
on the battlefield would assist and guide first responders in their clinical judgment and treatment of
these patients (Shoemaker et al., 2006). They found that the survivors of the study had mean values of
cardiac index and mean arterial pressure that were significantly higher than those of the non-survivors
thus reflecting the improved status of survivors’ cardiac, pulmonary, and tissue perfusion functions
(Shoemaker et al., 2006). The identification of these values early on as opposed to waiting for late signs
such as hypotension and conventional signs of shock and hypoperfusion allows for early treatment and
improved patient outcomes.
Dr. Shoemaker and his research team further examined the feasibility of noninvasive
hemodynamic monitoring for early recognition and identification of circulatory problems in patients
who had suffered thoracic and abdominal penetrating trauma injuries. The researchers again used a
thoracic bioimpedance monitoring device (improved from previous models) which allowed for quick and
easy application throughout the hospital environment (Asensio et al., 2006). They also compared their
noninvasive monitoring values to pulmonary artery thermodilution values after Swan-Ganz pulmonary
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artery catheters were placed postoperatively. The noninvasive cardiac output measurements were
combined with pulse oximetry for estimation of arterial hemoglobin saturation which was meant to
reflect pulmonary function; as well transcutaneous oxygen and carbon dioxide tensions which were
utilized to reflect tissue perfusion and oxygenation. The authors found that the noninvasive systems
provided essential clinical data early on that was previously unattainable without the presence of an
invasive monitor such as a pulmonary artery catheter. Early circulatory abnormalities were identified in
91% of these severe trauma patients (Asensio et al., 2006). Regarding the correlation between
noninvasive measurements and invasive measurements, the authors note that the differences in the
absolute values of each simultaneous reading was offset by the value of continuous trending data being
displayed by the noninvasive monitor (Asensio et al., 2006).
In yet another study directed towards examining the feasibility and reliability of
multicomponent noninvasive hemodynamic monitoring for trauma patients in the emergency
department and operating room, Dr. Shoemaker and his research team monitored 993 trauma patients
with major blunt or penetrating injuries shortly after admission to the emergency department.
Hemodynamic values were attained noninvasively by a thoracic bioimpedance device which was applied
shortly after arrival of the patient to the ED (Shoemaker et al., 2006). The authors noted that
application of the bioimpedance device simply entails applying leads, like an EKG, at the appropriate
positions on the thorax. Invasive hemodynamic values were attained via pulmonary artery
catheterization and a radial artery catheter (Shoemaker et al., 2006). The results demonstrated the
limits of agreement between the invasive and noninvasive methods were 19.7% and the average
difference between simultaneous noninvasive and invasive measurements was 9.7%. The authors
concluded that this data demonstrated satisfactory agreement between the two methods, however the
cost of noninvasive monitoring was only 11% of the cost associated with invasive pulmonary artery
catheterization and monitoring (Shoemaker et al., 2006). The authors made an important observation
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related to this research: in the early or incipient phase of trauma, shock frequently manifests as benign,
however subsequently patients are found to deteriorate rapidly leading to critical illness, organ failure,
and death (Shoemaker et al., 2006). The application of these noninvasive monitoring systems in the
early phase of trauma and shock development can provide essential hemodynamic information to guide
resuscitation before patients begin to deteriorate thus greatly improving their outcome. In addition,
patients’ response to treatment in this early stage is far greater than the response to treatment once
they become critically ill.
There is a gap in some of the research on this topic after 2006, which may be due to limitations
of noninvasive monitoring technology development. There were various noninvasive monitoring
devices in development during this time. In 2010 a meta-analysis was published by the American
Society of Anesthesiologists which examined the accuracy and precision of some minimally invasive
monitoring devices which measured cardiac output during surgery and critical care. They examined 4
different monitoring methods including esophageal doppler, partial carbon dioxide rebreathing, thoracic
bioimpedance, and pulse contour techniques (Peyton & Chong, 2010). The authors conducted a 10-year
review of studies with the goal of examining the level of agreement between noninvasive methods and
bolus thermodilution via pulmonary artery catheterization, the latter being considered the gold
standard for comparison. Interestingly, these authors found that none of the four noninvasive methods
met the criteria for acceptable agreement (determined in previous studies to be a percentage error of
30% or less) (Peyton & Chong, 2010). The weighted correlation coefficient was highest for thoracic
electric bioimpedance at 0.79 and lowest with partial carbon dioxide rebreathing at 0.57. The authors
recognized a significant number of limitations to their meta-analysis; of the 47 studies reviewed, 34
(72%) were done in cardiac surgery patients thus limiting the generalizability of the noninvasive devices
beyond the cardiac patient to other patient populations. Cardiac patients may have heart dysrhythmias,
valve disease, and other cardiovascular co-morbidities that limit the effectiveness of specific non-
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invasive monitors (Peyton & Chong, 2010). Another limitation was the 10-year time span of their metaanalysis. Noninvasive monitoring was a rapidly developing field and they were unable to reflect
improvements in newly available technologies. Findings did indicate the four monitoring methods
achieved limits of agreement between each other that were acceptable and the authors note that this is
significant as the methods utilize very different physical and physiological principles (Peyton & Chong,
2010). The absolute values derived from these noninvasive devices have been shown to be of less value
than the trending information they provide. “In major surgery, reliable real-time tracking of the
direction of changes in cardiac output is arguably more important than the ability of the monitor to
deliver a highly accurate single measurement under stable conditions” (Peyton & Chong, 2010).
A study published in 2012 examined how a lightweight trauma monitor could provide early
indication of central hypovolemia and tissue acidosis. The researchers used NIRS technology (nearinfrared spectroscopy) to determine muscle hemoglobin oxygen saturation and muscle hydrogen ion
concentration. This measurement of tissue pH is important as a clinical diagnostic value due to its
significantly increased sensitivity to the development of shock as opposed to measures of arterial and
venous pH (Soller et al., 2012). Noninvasive sensors were placed on the subject’s forearms which
collected reflectance spectra data from deep within the forearm muscle every 20 seconds. The
researchers placed subjects in a lower body negative pressure environment to simulate a model of preshock hemorrhage. The results demonstrated that muscle oxygenation decreased in proportion to
reductions in central blood volume with a strong positive relationship. The researchers also noted that
muscle oxygenation was one of the earliest indicators of progressive central hypovolemia as compared
with delayed alterations in standard vital signs. There was also a small yet significant reduction in
muscle pH once muscle oxygenation levels reached a critically low level (Soller et al., 2012). The authors
concluded that their research provided evidence that NIRS monitoring was capable of reflecting early
signs of blood loss which can indicate that splanchnic organs may be experiencing inadequate oxygen

NONINVASIVE HEMODYNAMIC MONITORING

10

delivery (Soller et al., 2012). This noninvasive measurement of muscle oxygenation and pH were shown
to be excellent indicators of early stage compensated shock. In addition, the NIRS monitoring system
was designed to be lightweight, small, and easy to use (Soller et al., 2012).
The Nexfin noninvasive monitoring device, developed by Edwards Life Sciences, uses an
inflatable finger cuff with a small box attached to the wrist which is used to indirectly measure finger
arterial blood pressure. This value is then placed in an algorithm which converts the finger arterial
pressure into beat-to-beat measurements of brachial blood pressures. In addition, the Nexfin device
provides cardiac output values based on pulse contour analysis (Chen et al., 2012). This device was
investigated in a study published in 2012 which assessed its ability to detect hypotension and
hypertension earlier than the standard blood pressure cuff in patients undergoing general anesthesia.
The sample included 25 patients referred for abdominal or orthopedic surgery. The researchers found
that the median percentage error of the Nexfin cuff compared to the standard blood pressure cuff was
40.3% (Chen et al., 2012). The authors concluded that a concordance of only 81.3% between standard
blood pressure readings and Nexfin readings necessitated further research to determine the accuracy of
the Nexfin device (Chen et al., 2012). The real value of the Nexfin may be in observing trends of blood
pressure which can assist in early detection of blood pressure changes and lead to timely intervention
thus improving patient outcomes.
The NICOM (Noninvasive Cardiac Output Monitor) is another device based on thoracic
bioimpedance technology which was developed by Cheetah Medical Inc. This device was utilized in a
research study examining how noninvasive cardiac output measurements in the emergency department
are associated with trauma activation, patient injury severity, and length of stay (Dunham et al., 2012).
The NICOM sensors were applied to the torso after patients arrived to the emergency department at a
Level I trauma center and monitoring was continued for 60 to 90 minutes. Cardiac output
measurements were achieved easily and quickly once the sensors were in place. 270 patients were
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included in the study with NICOM cardiac outputs available from 242, or 89.6%. The researchers found
that the NICOM cardiac output values were significantly useful as they displayed appropriate variations
with injury severity, co-morbidity, and survival in acutely injured trauma patients. The cardiac outputs
were shown to be significantly higher in hypotensive patients who were not hemorrhaging as opposed
to hypotensive patients that were hemorrhaging (Dunham et al., 2012). This was used to assist the
clinician in choosing the appropriate treatment (I.e. fluids vs. vasopressors). Patient length of stay was
shown to be increased in non-survivors (compared to non-survivors without NICOM who succumbed
faster), but decreased in survivors (compared to survivors without NICOM that experienced increased
complications requiring lengthier treatment) (Dunham et al., 2012). The NICOM device was found to be
capable of providing objective, clinically valid, relevant, and discriminate cardiac output data in this
adult acute trauma patient population (Dunham et al., 2012).
The Nexfin monitor was the subject of another research study published in 2013 which
examined the validation of the device against continuous pulse contour and intermittent
transpulmonary thermodilution via pulmonary artery catheter. Continuous pulse contour analysis was
done via the PiCCO system (a less invasive system that requires a central line and arterial line, however
still uses noninvasive pulse contour analysis to measure cardiac output) (Ameloot et al., 2013). The
study included 47 critically ill patients admitted to the medical, surgical, and burn intensive care units at
a major medical center. Results showed moderate to good correlation coefficients with the pulmonary
artery catheter thermodilution method (0.68) and PiCCO method (0.71). The percentage errors were
considered too high however to be considered clinically acceptable; the authors cited other research
studies that came to similar conclusions when investigating the validity of the Nexfin device (Ameloot et
al., 2013). The Nexfin device was found to be most accurate in patients with a high cardiac output and
low systemic vascular resistance and least accurate in patients with the opposite characteristics such as
in trauma and sepsis patients. Additionally, the Nexfin produced unreliable data in hypothermic
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patients (Ameloot et al., 2013). The authors concluded that the Nexfin device may be an appropriate
initial hemodynamic assessment that could act as a bridge to placement of more invasive/accurate
monitoring systems. The value of the device may be found in tracking changes in cardiac output rather
than relying on absolute values to determine cardiac output (Ameloot et al., 2013).
There was increased research on the various noninvasive hemodynamic monitoring systems as
technologies continued to be modified and improved over time. The NICOM (Cheetah Medical) was
investigated as being a feasible option for hemodynamic monitoring of air-evacuated casualties in a
2013 study. The study examined 16 patients who were air evacuated by the French army health service
and placed on the NICOM monitor (Dubost et al., 2013). The researchers found that the monitor was
feasible for transport during long flights without any signal loss or interferences noted and monitoring
allowed for fine-tuning of fluid management in these unstable trauma patients (Dubost al., 2013).
Partial end-tidal carbon dioxide is another noninvasive monitoring method that has been
utilized to determine cardiac output in patients. Dunham et al. (2013) investigated the statistical
relationship between cardiac output and end-tidal carbon dioxide while at the same time correlating
cardiac output levels with patient injury severity levels, blood pressure, heart rate, blood loss,
transfusions, abnormal pupils, cardiac arrest, and death (Dunham et al., 2013). They reviewed 73
emergently intubated patient's records who had NICOM cardiac output monitors in place. They found
that low end-tidal carbon dioxide levels were associated with low cardiac output and patients with
major blood loss had a significant reduction in both of these values. Patients who were hypotensive but
did not have blood loss displayed normal cardiac output and end-tidal levels implying that cardiac
output and end-tidal carbon dioxide values may be helpful in making clinical decisions when managing
hypotensive trauma patients (Dunham et al., 2013). The authors found that preserved cardiac output
and end-tidal carbon dioxide levels in the hypotensive trauma patient implied the absence of blood loss.
The authors do note that low levels do not necessarily indicate that there is hemorrhage as there can be
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other causes of low cardiac output and end-tidal carbon dioxide (cardiac contusions, tamponade,
tension pneumothorax, or heart failure) (Dunham et al., 2013).
Masimo is another company that has developed noninvasive hemodynamic monitoring devices;
their Radical 7 system has been approved to measure hemoglobin noninvasively via a
spectrophotometric self-calibrating sensor with light-emitting diodes and a photodetector which
analyzes the patient via a finger probe (Moore, et al, 2013). Hemoglobin is commonly used to assist in
identifying hemorrhage in trauma patients; trending these levels continuously would assist the clinician
in identifying and treating blood loss. The system was investigated in a research study published in 2013
in order to evaluate the accuracy of the sensor hemoglobin levels to lab drawn hemoglobin levels. The
patient sample was 525 trauma admissions for which 418 had readable outputs from the finger probe
(Moore et al, 2013). The correlation between the sensor and lab drawn hemoglobin levels was found to
be poor and in addition the device failed to detect hemoglobin values in 34% of the readouts. The
authors note previous studies on this device have shown good clinical correlation in euvolemic patients;
however accuracy was poor in patients with trauma and suspected blood loss (Moore et al., 2013). The
Radical-7 was concluded to have limited clinical application in patients with hemorrhagic shock/trauma.
The Nexfin device was the subject of another study in 2014 which investigated whether the
device could help diagnose patients suffering from suspected heart failure, sepsis, and stroke (Nowak et
al., 2014). The researchers enrolled 514 subjects in the study with 4 excluded due to suspected finger
cuff failure of the Nexfin unit. The data retrieved from the subjects showed that cardiac index and
stroke volume index, as measured by the Nexfin, were highest in sepsis, followed by stroke, and lowest
in acute heart failure (Nowak et al., 2014). The authors concluded that the data from the Nexfin could
play a potential role in helping to diagnose and individualize treatment for this population of patients in
the future (Nowak et al, 2014.)
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The Nexfin has also been studied for its ability to measure pulse pressure variation and stroke
volume variation for the monitoring of intraoperative fluid shifts. A 2014 research study observed 54
patient's response to a provoked fluid shift (patients were placed in Trendelenberg position). The Nexfin
was able to reflect alterations in the pulse pressure variations and stroke volume variation while mean
arterial pressure and cardiac index were not sensitive enough to reflect any changes (Stens et al, 2014).
The Nexfin derived values of pulse pressure variation and stroke volume variation were of additional
value to static indices for clinical assessment of fluid shifts in patients under anesthesia (Stens et al.,
2014). The authors do note the limitation of the Nexfin's accuracy, "Nexfin cardiac values have proven
to be unreliable in studies with critically ill patients, since they included patients with potentially
compounding factors due to abnormal vascular tone, peripheral hypoperfusion due to septic shock, or
cardiac stunning" (Stens et al., 2014). Trauma patients generally fall into the category of critically ill,
which would limit the usefulness of the Nexfin device for this purpose.
The Radical-7 by Masimo was investigated in another research study designed to assess the
accuracy of continuous noninvasive hemoglobin monitoring for the prediction of blood transfusion in
trauma patients (Galvagno et al., 2014). The study enrolled 1191 patients of which 711 had available
hemoglobin data obtained from the Radical-7 device. Subjects had the finger probe sensor applied upon
admission to a trauma resuscitation unit with the primary outcome of interest being the administration
of at least one unit of packed red blood cells within the first 12 hours (Galvango et al., 2014). Results
showed that hemoglobin monitoring by the Radical-7 alone did not enhance predictive models showing
the need for blood transfusion, however when combined with continuous vital signs, and adjusted for
age and sex, the predictive value had good accuracy (Galvango et al., 2014). The researchers concluded
that, in the trauma population, the cost of implementing such a device could not be justified until
development of devices with increased accuracy (Galvango et al., 2014).
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Joseph et al. (2015) examined the Radical-7 by Masimo, this time in the setting of trauma
patients. The researcher's goal was to evaluate the efficacy and accuracy of a spot check noninvasive
hemoglobin measuring device compared to invasive laboratory measurements in trauma patients
(Joseph et al., 2015). The study sample included 525 patients with a successful readability rate of 86%
thus reducing the sample to 450. They found that the difference between mean hemoglobin values of
the noninvasive and invasive methods was only 0.3 g/do (plus or minus 3.6 g/do). The noninvasive spot
check measurements were shown to have a strong correlation with the invasive measurements with
76% accuracy and 95.4 % accuracy (Joseph et al., 2015). The failure of the device to capture readings in
75 (14%) patients and the inconsistency of the device to collect measurements may be due to several
factors such as low perfusion states, motion artifact, and disconnection of the sensor. In conclusion, the
authors state that the inability of the device to recognize readings in trauma patients with lifethreatening hemorrhage is a failure of the device and as a result, further evaluations need to be done
before implementation of the device into clinical practice (Joseph et al., 2015).
The NICOM, a thoracic bioimpedance noninvasive cardiac output monitor, was the subject of
investigation by researchers Berlin et al. in a study published in 2017 which was designed to test the
researcher's hypothesis that the NICOM has acceptable agreement with bolus thermodilution from a
pulmonary artery catheter in a wide range cardiac outputs. The researchers used a porcine model (8
Yorkshire swine weighing between 48-55 kg) of hemorrhagic shock and resuscitation as their model
(Berlin et al., 2017). The data they collected and analyzed suggested an acceptable agreement between
the invasive and noninvasive methods with a strong correlation between simultaneous measurements.
The authors demonstrated a 97% concordance of values as plotted on a four-quadrant x/y axis. They
made a distinction of cardiac output measurements that had also been made by other researchers:
"Given the inherent error of all cardiac output monitoring (whether noninvasive or invasive), trending
may be more important than the absolute values" (Berlin et al., 2016). The generalizability of the
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porcine model to the human model is a limitation of the study although the authors claim this
substitution is supported by previous use of porcine models to evaluate cardiac output monitors. The
model used in this study claimed similar clinical features to human hemorrhage and resuscitation (Berlin
et al., 2016).
A recent development in the field of noninvasive hemodynamic monitors is the Cipher Ox CRI
(compensatory reserve index) tablet (tablet is their monitor platform, not an oral medication). The CRI
is a new hemodynamic parameter which trends changes in a patient's intravascular volume relative to
the individual patient's response to hypovolemia (Moulton et al., 2017). This index was just approved
for use by the FDA in December of 2016. The CRI is a cardiovascular status indicator which is derived
from a mathematical equation that equates the proportion of additional volume loss a patient can
tolerate before hemodynamic decompensation occurs. CRI values range from 1 to 0 with 1 representing
100% and 0 representing 0%. The 1 corresponds to supine normovolemia while 0 implies imminent
decompensation and circulatory collapse. The CRI decreases as a patient experiences volume loss,
whether from bleeding or dehydration and CRI increases as the patient receives volume resuscitation.
Patient tolerance to volume loss is different from individual to individual due to various factors such as
ambient temperature, pain, medications, comorbidities, and innate physiologic capacity to compensate
for volume loss (Moulton et al., 2017). The Cipher Ox tablet, which measures CRI via a finger probe,
was evaluated in a research study that showed the CRI did have the ability to accurately, continuously,
and noninvasively trend changes in intravascular volume for individual patients who experience
moderate volume loss and replacement. Patients who had limited innate tolerance for volume loss had
lower CRI estimates after blood loss than subjects who had a higher tolerance thus demonstrating the
device's ability to individualize the CRI measurement effectively (Moulton et al., 2017). The clinical value
of this device is observed as CRI values decrease over time which is indicative of rapid progression to
hemodynamic decompensation due to central volume loss. The CRI has been shown to be far more
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sensitive to volume loss than traditional monitoring methods when patients are asymptomatic (early
phase of acute injury) and has also been shown to have increased accuracy in anticipating cardiovascular
collapse when compared to derived parameters such as pulse pressure index and pulse pressure
variation (Moulton et al., 2017). The limitation of this study is its application to trauma patients who
have experienced major volume loss. The authors simulated blood loss by removing 333ml per subject
rather than a percentage of blood loss per person. Other noninvasive hemodynamic monitoring
systems that utilize finger sensor technology have proven to be accurate in normovolemic patients but
inaccurate in patients that have undergone major volume loss (Moulton et al., 2017). The Cipher Ox
tablet needs to be evaluated in the setting of the emergency trauma patient before introduction of this
device into clinical practice with these types of patients.
In a recent study published in July of 2017, Masimo's Radical-7 probe was again evaluated for
hemoglobin monitoring specifically in trauma patients. The subjects of this study were 113 trauma
patients who already had hemoglobin levels less than 8gm/dL. Forty-three patients were excluded due
to hemoglobin levels higher than 8gm/dL leaving 70 patients to be included in the study (Gamal et al.,
2017). The researchers found low bias and strong correlation between noninvasive hemoglobin values
and lab drawn values with a Pearson correlation coefficient of 0.872. The mean Radical-7 value for all
samples was 6.7 gm/dL while the mean lab drawn value was 6.5 gm/dL (Gamal et al., 2017). Patients
were measured at various stages in patient management including the resuscitation, preoperative, and
intraoperative phases. The authors note that although all of their subjects were experiencing active
bleeding, none of the subjects were in shock which may be an important limitation as the Masimo
device has been shown to be more accurate in patients with adequate perfusion (Gamal et al., 2017).
They conclude that the Radical-7 showed accurate precision in both absolute values and trend values
compare to lab drawn measurements in trauma patients (Gamal et al, 2017).
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The use of noninvasive hemodynamic monitoring in the clinical setting has been steadily
increasing as evidence shows that hemodynamic instability and hypoperfusion are major contributing
factors for organ failure and death. Invasive hemodynamic techniques have important limitations,
especially towards treatment of trauma patients; this is evidenced by the time and personnel needed for
pulmonary artery catheter placement. There are dangerous complications that can accompany this
procedure as well such as central infection, blood vessel damage, severe bleeding, pneumothorax,
damage to cardiac valve structures, and dangerous arrhythmias (Kuster, Exadaktylos, and Schnuriger,
2015). Noninvasive techniques offer a solution by allowing for easy, quick, and early application in the
clinical and emergency setting during the initial evaluation of the patient. Noninvasive monitoring
interferes less with clinical management than invasive methods and provides a continuous real-time
display of measurements which permits early recognition of altered hemodynamic status compared to
traditional monitoring methods in the early stages of trauma patient management (Kuster, Exadaktylos,
and Schnuriger, 2015). The accuracy of various noninvasive techniques has been the subject of
numerous research studies as seen in this literature review. Overall, the NICOM device has been shown
to have the best accuracy in trauma patients with the Nexfin device providing the least accurate
information, however each method has unique advantages and disadvantages which need to be
acknowledged by the clinician. There is evidence pointing in different directions for the overall accuracy
of specific devices. The research suggests that the best approach may be to utilize noninvasive
monitoring as an adjunct to other patient information and data when making treatment decisions.

Discussion
The ability of the anesthesia provider to understand and effectively use these monitoring
systems for their patients is essential. The value of these devices lies in providing early hemodynamic
data that would otherwise only be attainable via placement of invasive monitors. Application of these
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devices should be done by qualified pre-hospital emergency services or by emergency department
providers once the patient has arrived at the hospital. This critical window of time in emergency trauma
patients is invaluable at directing early resuscitation efforts and fluid replacement. Patients in the early
stages of shock will not necessarily display changes in basic parameters such as vital signs, mental status,
urine output, skin color, and temperature which makes early diagnosis and treatment of shock related
to trauma extremely difficult. Early application of noninvasive hemodynamic monitoring can provide
early warnings of impending shock and thus guide appropriate preemptive treatment which would assist
in preventing the rapid deterioration that occurs in the later stages of shock. For those patients that
require immediate life-saving surgery, the early resuscitation administered based on derived
noninvasive hemodynamic data would greatly assist the anesthesia provider preparing to place the
patient under anesthesia. These patients should have increased hemodynamic stability in the face of
traumatic shock and the anesthesia provider will have a better idea of how their status is trending with
regards to cardiac output and/or blood loss.
The NICOM device, a thoracic bioimpedance device which is applied with 4 leads on the thorax
similar to ECG leads, has been shown to have the greatest accuracy for cardiac output compared to
other devices although it has limitations as well. Funk, Moretti, and Tong (2009) explain that thoracic
bioimpedance is affected by tissue fluid volume as well as volume changes of pulmonary and venous
blood that are induced by respiration. As a result, this interference must be filtered out from the
desired changes in volumetric blood flow of the aorta. Alterations in the position or contact of the
electrodes will thus affect these measurements (Funk, Morreti, and Tong, 2009). Cardiac irregularities
including dysrhythmias, valve disease, and right heart failure can also contribute to limiting the
effectiveness of these devices. Newer devices have overcome some of these challenges by increasing
signal processing as well as improving signal filtering, ECG triggering, arrhythmia detection, and
respiratory filtering (Funk, Morreti, and Tong, 2009). Application of a thoracic bioimpedance monitoring
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system would ideally be in the field or ambulance while on route to a level 1 trauma center, however
placement in the emergency department would also be effective in identifying early changes in
hemodynamic status. This monitor may become of less value once the patient is moved into the
operating room and surgery commences as the intraoperative environment is less conducive to accurate
measurements of cardiac output due to interference by noise from electrocautery, mechanical
ventilation and surgical manipulation (Funk, Morreti, and Tong, 2009). The goal is for early resuscitation
to be administered prior to the patient entering the operating room. In doing so, this will have
prevented the patient from rapidly decompensating while additionally buying time for anesthesia
personnel who are able to place more invasive lines once surgery has begun.
The noninvasive finger-cuff devices include the Nexfin device, which has been re-developed into
the ClearSight system by Edwards Lifesciences. This technology utilizes a volume clamp method; this
involves clamping the artery to a constant volume by dynamically providing equal pressure on either
side of the arterial wall. The volume is measured by a photo-plethysmograph built into the cuff. The
counter pressure is applied by an inflatable bladder inside the cuff and is adjusted 1000 times per
second to keep the arterial volume constant. Edwards utilizes a mathematical real-time calculation
referred to as Physiocal which determines the proper arterial ‘unloaded’ volume, i.e. the volume
without a pressure gradient across the arterial wall. Per Edwards, the Physiocal method can analyze the
curvature and sharpness of the plethysmogram during short episodes of constant pressure levels.
Physiocal then automatically and periodically recalibrates the system to allow for accurate tracking of
physiologic changes (Edwards Lifesciences, 2018). Like thoracic bioimpedance, this device can be
applied in the pre-hospital setting by emergency services or in the emergency department and provide
hemodynamic information including cardiac index, stroke volume, stroke volume variation, systemic
vascular resistance and continuous blood pressure. One of the drawbacks associated with previous
Nexfin technology has been the loss of accuracy in patients that are already hemodynamically
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compromised and have low peripheral vascular resistance. Trauma patients are likely to fall into this
category thus limiting the effectiveness of these devices in this patient population. Edwards reports
improved accuracy with their most recent incarnation of Nexfin technology, the ClearSight system. One
of the positive aspects of this device is that it can be brought into the OR with the patient and not suffer
from interference caused by electrocautery. The device is also not likely to interfere with surgical prep
or procedure as it stays on the patient’s finger and wrist. Patient limiting factors that apply to this
device include peripheral vascular disease, Raynaud’s disease, or any other condition that affects
circulation to the extremities.
The minimally invasive technologies that utilize pulse contour analysis were not included in the
literature review as they require some invasive lines to function (usually an arterial line). These devices,
which include the PiCCO, LiDCO, and FloTrac, are worth mentioning as they offer the same
hemodynamic information provided by the noninvasive monitors however with improved accuracy as
they are calibrated to an invasive line. These systems have drawbacks of their own though as pulse
contour cardiac output measurements rely on a good quality of arterial trace; as a result, overdamping
or underdamping can lead to unreliable cardiac output measurements (Critchley, 2011).
A noninvasive hemodynamic monitoring method that was not identified in the literature review
is the esophageal doppler which utilizes ultrasound technology to measure cardiac output. The
advantages of using Doppler technology include the ability to remain in position for days to weeks, its
proximity to the aorta, and the size of the probe which is approximately the size of a nasogastric tube
and can be positioned easily (Funk, Morreti, and Tong, 2009). Doppler technology relies on physiological
assumptions such as the aorta being cylindrical shaped and predetermines the patient’s aortic radius
based on age, sex, weight, and height from which it calculates stroke volume based on pulsatile aortic
blood flow (Funk, Morreti, and Tong, 2009). Esophageal doppler only measures descending aortic blood
flow (70% of cardiac output), excluding blood flow to the aortic arch vessels, and as a result a correction
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factor of 30%is introduced into the calculation of cardiac output. While this correction factor has been
shown to be accurate in healthy individuals, the correction constant may not be suitable for patients in
shock whose hemodynamic status may be undergoing drastic changes (Funk, Morreti, and Tong, 2009).
Another limitation of this technology is that correct and accurate measurements are operator
dependent and there is a relatively (compared to other noninvasive monitoring devices) steep learning
curve. Probe position is critical to obtain accurate flow measurements and as a result additional training
is necessary for staff to utilize this technology correctly. While esophageal doppler cardiac output
measurements have been shown to have the highest accuracy when used correctly, this technology may
not be ideal for trauma patients who are unstable as there may be spurious measurements recorded in
the chaotic environment which usually surrounds an incoming trauma patient to the hospital. This
technology may be of more use once the patient has been brought into the OR and anesthesia induction
has commenced. Trans-esophageal echocardiogram ultrasound is a similar option for the patient in the
operating room; this technology is also operator dependent as the provider must be trained to correctly
perform a TEE to obtain accurate cardiac output values.
Masimo’s noninvasive systems do not offer cardiac output measurements, however they do
provide total hemoglobin, methemoglobin, carboxyhemoglobin, oxygen saturation, oxygen content, and
pleth index from their Rainbow SET monitoring platform. The literature is variable on the accuracy of
Masimo’s devices. The most recent article on Masimo’s noninvasive monitoring system published in
2017 shows a good correlation between lab drawn hemoglobin values and hemoglobin values derived
from Masimo’s finger probe. One of the issues that has been found to limit the accuracy of these
devices (which was also a limitation with the Nexfin finger cuff technology) is patients who are in active
decompensating shock. Studies have shown that the accuracy of these devices was reduced significantly
in patients with severely compromised hemodynamic statuses. On the other hand, these devices are
excellent for trending hemoglobin levels which may assist the provider in making the decision to
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transfuse blood products. Literature suggests not relying solely on these devices to make a transfusion
decision; its optimal use would be in assisting the provider to make a judgment in conjunction with
other patient diagnostic information (vital signs, labs, urine output, surgical blood loss).
Each of these various noninvasive hemodynamic monitoring systems has been studied and used
by clinicians with the goal of optimizing patient outcomes. The anesthesia provider who decides to
utilize noninvasive monitoring for their patient needs to understand the appropriate application of these
devices as well as the limitations that exist with each of these systems. The trauma patient would
benefit most from noninvasive monitoring in the early stages of injury and shock where appropriate
resuscitation would prevent acute decompensation. The patient’s odds of a positive outcome following
trauma surgery greatly increase if the acute decompensation of shock can be prevented or delayed. The
provider should also recognize that the technology of these devices is always advancing. It is essential
for the provider to continue to read the literature and studies on these devices as they progress and
decide for themselves the appropriate use and value as pertains to their individual patient.
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